Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
about
Bundling occupational safety with harm reduction information as a feasible method for improving police receptiveness to syringe access programs: evidence from three U.S. citiesExercise-based treatments for substance use disorders: evidence, theory, and practicalityQTc interval screening for cardiac risk in methadone treatment of opioid dependenceMedia campaigns for the prevention of illicit drug use in young peoplePsychosocial interventions for supporting women to stop smoking in pregnancyHeroin maintenance for chronic heroin-dependent individualsAntidepressants for cocaine dependence and problematic cocaine useMedia Campaigns for the prevention of illicit drug use in young peopleOral naltrexone maintenance treatment for opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsPharmacological treatment for depression during opioid agonist treatment for opioid dependenceHeroin maintenance for chronic heroin-dependent individualsOral naltrexone maintenance treatment for opioid dependenceInterventions for promoting smoking cessation during pregnancySustained-Release Naltrexone For Opioid DependenceHeroin maintenance for chronic heroin dependentsMethadone maintenance at different dosages for opioid dependenceCurrent quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatmentAn Exploratory Investigation of the Association between Clinicians' Attitudes toward Twelve-step Groups and Referral Rates.State of the art treatments for cannabis dependenceEvidence-based practices for substance use disordersEpigenetic mechanisms underlying extinction of memory and drug-seeking behaviorA "SMART" design for building individualized treatment sequencesAn exploration of the effect of on-site 12-step meetings on post-treatment outcomes among polysubstance-dependent outpatient clientsThe sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinkingRisky Substance Use Environments and Addiction: A New Frontier for Environmental Justice ResearchVentral Tegmental Area Afferents and Drug-Dependent BehaviorsCellular Mechanisms of Action of Drug Abuse on Olfactory NeuronsUpdate on medicines for smoking cessationPrescription Sedative Misuse and AbuseMobile Delivery of Treatment for Alcohol Use Disorders: A Review of the LiteratureA pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersFinancing prevention: opportunities for economic analysis across the translational research cycleComparing treatments for dual diagnosis: twelve-step and self-management and recovery trainingImproving personality/character traits in individuals with alcohol dependence: the influence of mindfulness-oriented meditationD-cycloserine effects on extinction of conditioned responses to drug-related cuesL-theanine inhibits nicotine-induced dependence via regulation of the nicotine acetylcholine receptor-dopamine reward pathwayAddiction treatment and stable housing among a cohort of injection drug usersPartial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addictionCue reactivity is associated with duration and severity of alcohol dependence: an FMRI study
P2860
Q21245628-4ED94FD4-27A7-4290-873A-C5A8508B9F38Q22241262-54108207-4D57-490F-8E22-E4566B2C60DBQ24201880-317F30CB-1E9D-466E-82AF-CAD7CFD9EF25Q24202193-AAE32CCE-1701-453E-8F2C-7A26DA5FD160Q24202931-827B026E-3F40-40CC-9B4D-1D46B593F969Q24234080-C44F8D8C-76FA-4E12-B777-A28B86DB22FDQ24234248-B7512382-A9B9-4752-9459-95FBF0B2D3B4Q24234801-F4CDFE19-3F89-4725-8A14-D8362069BEBBQ24235092-E9CE2B49-05AF-4CC5-881D-FCC275747545Q24235379-2478A7D2-939A-4190-BF41-8E7AC49A2409Q24235458-A5D0FDE5-0BF0-42C2-81EE-DD045350FF2CQ24236411-53FD8D30-861C-44A5-B799-2D87B54285E8Q24236708-DAFB6880-C61E-48C4-AA1D-10819A290B4BQ24240117-D05CF031-E2DE-44A4-8A80-8C9E33177DECQ24243205-082A1192-3B46-4AF3-98B8-92DF5F881D33Q24244103-C720FE5A-20B7-4599-A429-1AAEDBC83F01Q24248013-9524889E-A4EC-4D52-B36F-DB99E0A8F1ECQ24289464-18663740-0065-4AE0-9706-609E8B62795FQ24538584-1A6DE41A-C791-42A5-826C-BF5A64629DD8Q24607810-02CD867B-598C-414A-B585-E8AB923688F9Q24614016-D76F68CF-F032-41B7-B09D-649CF97D9CA3Q24615107-7AA27620-1133-466D-A92C-2FA51169D52FQ24619631-7179D3C8-02A9-4775-8B42-7C4A9B157679Q24649673-4B6912C6-6715-4811-854A-12725E784AAFQ24658287-E0262047-7D75-48EF-9549-F3CB5C8982F3Q26744333-04D64C94-0E8C-4B19-A9D0-5EF87A16E076Q26751118-4D2EE74A-5FD2-4A19-AC99-F186FCAFE7A2Q26772009-A6E27D39-B61A-42E7-BC91-E92B3B795B39Q26773281-65C27827-4E5C-4BA1-BD43-2D116F51654BQ26785474-60C18847-10D6-4F61-9C96-FB18BC0CC875Q26799833-EAC1CB55-9725-4C21-A44C-E641261AD5E4Q27000732-C947275C-1839-43FD-9A96-7E428A3C6619Q28077941-2A98570D-A5CF-4F88-A2A7-90B93BD19302Q28206227-E8BC0E97-C3F9-485B-A2E1-D8BB5C6F2F07Q28255481-63CEEF75-FB0E-4042-BAC4-94B7713D0CB6Q28266461-C5CD053C-841D-457E-9B5F-D28ADBBAB069Q28281281-D500CE26-2A79-4F0C-8891-A209C8FF6319Q28474879-7BD4D443-1D1E-4808-A00C-2097345378E9Q28486981-817C23F7-0603-4AFA-852A-67B04E30F1AAQ28538333-D5594D95-15F2-4FFD-93B9-3C98276D6145
P2860
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@ast
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@en
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@nl
type
label
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@ast
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@en
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@nl
prefLabel
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@ast
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@en
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@nl
P2093
P3181
P356
P1476
Drug dependence, a chronic med ...... rance, and outcomes evaluation
@en
P2093
A T McLellan
C P O'Brien
H D Kleber
P304
P356
10.1001/JAMA.284.13.1689
P407
P577
2000-10-04T00:00:00Z